RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats

Hypertension Research

Volumn 27, Issue 4, 2004, Pages 263-270

  Moriki, Nobuyuki ^a   Ito, Masaaki ^a   Seko, Tetsuya ^a   Kureishi, Yasuko ^a   Okamoto, Ryuji ^a   Nakakuki, Tetsuya ^a   Kongo, Mariko ^a   Isaka, Naoki ^a   Kaibuchi, Kozo ^b   Nakano, Takeshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclic GMP dependent protein kinase 1 ; RhoA; Smooth muscle cell; Stroke prone spontaneously hypertensive rats; Valsartan

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN; CPI 17 PROTEIN; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE IALPHA; CYCLIC NUCLEOTIDE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE BETA; MYOSIN LIGHT CHAIN KINASE; MYOSIN PHOSPHATASE TARGET SUBUNIT 1; PHOSPHOPROTEIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL CELL; AORTA; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; MOLECULAR DYNAMICS; NONHUMAN; PARACRINE SIGNALING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; CELLS, CULTURED; CEREBROVASCULAR ACCIDENT; CYCLIC AMP; CYCLIC GMP; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; PRAZOSIN; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TETRAZOLES; VALINE;

EID: 2342580708     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.263     Document Type: Article

References (44)

1. Hartshorne DJ: Biochemistry of the contractile process in smooth muscle, in Johnson LR (eds): Physiology of the Gastrointestinal Tract. New York, Raven Press, 1987, pp 432-482.
2. Somlyo AP, Somlyo AV: Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-236.
3. 2+, protein kinase C and myosin light chain phosphatase. Jpn Heart J 1996; 37: 793-813.
4. Somlyo AP, Somlyo AV: Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. Am J Physiol 2000; 522: 177-185.
5. Noda M, Yasuda-Fukazawa C, Moriishi K, et al: Involvement of rho in GTPγS-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett 1995; 367: 246-250.
6. Kimura K, Ito M, Amano M, et al: Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273: 245-248.
7. Kaibuchi K, Kuroda S, Amano M: Regulation of the cytoskeleton and cell adhesion by the Rho family GTPase in mammalian cells. Anna Rev Biochem 1999; 68: 459-486.
8. Feng J, Ito M, Ichikawa K, et al: Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 1999; 274: 37385-37390.
9. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F: A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C: isolation from porcine aorta and characterization. J Biochem 1995; 118: 1104-1107.
10. Eto M, Senba S, Morita F, Yazawa M: Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI-17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 1997; 410: 356-360.
11. Koyama M, Ito M, Feng J, et al: Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 2000; 475: 197-200.
12. Wu X, Haystead TA, Nakamoto RK, Somlyo AV, Somlyo AP: Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin: synergism with cyclic nucleotide-activated kinase. J Biol Chem 1998; 273: 11362-11369.
13. Wu X, Somlyo AV, Somlyo AP: Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate. Biochem Biophys Res Commun 1996; 220: 658-663.
14. 2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 1997: 272; 5063-5068.
15. Lang P, Gesbert F, Delespine-Carmagnat M, Stancon R, Pouchelet M, Bertoglio J: Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J 1996; 15: 510-519.
16. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 2000; 275: 21722-21729.
17. Sawada N, Itoh H, Yamashita J, et al: cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 2001; 280: 798-805.
18. Uehata M, Ishizaki T, Satoh H, et al: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990-994.
19. Kip1 expression in the vasculature of hypertensive rats. Circ Res 2001; 89: 488-495.
20. Mukai Y, Shimokawa H, Matoba T, et al: Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 2001; 15: 1062-1064.
21. Ito K, Hirooka Y, Sakai K. et al: Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nerve system. Circ Res 2003; 92: 1337-1343.
22. Seko T, Ito M, Kureishi Y, et al: Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 2003; 92: 411-418.
23. Taya S, Inagaki N, Sengiku H, et al: Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF. J Cell Biol 2001; 155: 809-820.
24. Inagaki N, Nishizawa M, Ito M, et al: Myosin binding sub-unit of smooth muscle myosin phosphatase at the cell-cell adhesion sites in MDCK cells. Biochem Biophys Res Commun 1997; 230: 552-556.
25. Ito M, Guerrireo V Jr, Chen XM, Hartshorne DJ: Definition of the inhibitory domain of smooth muscle myosin light chain kinase by site-directed mutagenesis. Biochemistry 1991; 30: 3498-3503.
26. Ren XD, Kiosses WB, Schwartz MA: Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 1999; 18: 578-585.
27. 2+ influx by sarcoplasmic reticulum in femoral arteries from spontaneously hypertensive rats at prehypertensive stage. Hypertens Res 2001; 24: 271-282.
28. 2+ buffering function of the sarcoplasmic reticulum is increased in the carotid artery from spontaneously hypertensive rats. Hypertens Res 2002; 25: 221-230.
29. Shimizu E, Ohyanagi M, Masutani M, Iwasaki T: A decrease in the amount and function of the stimulatory GTP-binding protein in the small resistance arteries of spontaneously hypertensive rats. Hypertens Res 2002; 25: 743-749.
30. Wettschureck N, Offermanns S: Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med 2002; 80: 629-638.
31. Shimokawa H: Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 2002; 39: 319-327.
32. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A: Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2000; 38: 1307-1310
33. Sakurada S, Okamoto H, Takuwa N, Sugimoto N, Takuwa Y: Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol 2001; 281: C571-C578.
34. Dzau VJ: Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77: 14-113.
35. Fukuda N, Satoh C, Hu WY, et al: Production of angiotensin II by homogenous culture of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1999; 19: 1210-1217.
36. Kourlas PJ, Strout MP, Becknell B, et al: Identification of a gene 11q23 encoding a guanine nucleotide factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000; 97: 2145-2150.
37. Kozasa T, Jinag X, Hart MJ, et al: p115RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 1998; 280: 2109-2111.
38. Fukuhara S, Murga C, Zohar M, Igishi T, Gutkind JS: A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G protein to Rho. J Biol Chem 1999; 274: 5868-5879.
39. Fukuhara S, Chikumi H, Gutkind JS: Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links heterotrimeric G proteins of the G12 family to Rho. FEBS Lett 2000; 485: 183-188.
40. Kozasa T, Jiang X, Hart MJ, et al: p 115 RhoGEF, a GTPase activating protein for Gα12 and GΑ13. Science 1998; 280: 2109-2111.
41. Gohla A, Schultz G, Offermann S: Role for G12/G13 in agonist-induced vascular smooth muscle cell contraction. Circ Res 2000; 87: 221-227.
42. Ellerbroek SM, Wennerberg K, Burridge K: Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem 2003; 278: 19023-19031.
43. Manganello JM, Huang JS, Kozasa T, Voyno-Yasenetskaya TA, Le Breton GC: Protein kinase A-mediated phosphorylation of the Gα13 switch I region alters the Gαβγ13-G protein-coupled receptor complex and inhibits Rho activation. J Biol Chem 2003; 278: 124-130.
44. Ruetten H, Zabel U, Linz W, Schmidt HH: Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 1999; 85: 534-541.